Ontology highlight
ABSTRACT: Background
11?-hydroxysteroid dehydrogenase 1 (11?-HSD1) interconverts active 11?-hydroxyl glucocorticoids and inactive 11keto forms. However, its directionality is determined by availability of NADP+/NADPH. In liver cells, 11?-HSD1 behaves as a primary reductase, while in Leydig cells it acts as a primary oxidase. However, the exact mechanism is not clear. The direction of 11?-HSD1 has been proposed to be regulated by hexose-6-phosphate dehydrogenase (H6PDH), which catalyzes glucose-6-phosphate (G6P) to generate NADPH that drives 11?-HSD1 towards reduction.Methodology
To examine the coupling between 11?-HSD1 and H6PDH, we added G6P to rat and human liver and testis or Leydig cell microsomes, and 11?-HSD1 activity was measured by radiometry.Results and conclusions
G6P stimulated 11?-HSD1 reductase activity in rat (3 fold) or human liver (1.5 fold), but not at all in testis. S3483, a G6P transporter inhibitor, reversed the G6P-mediated increases of 11?-HSD1 reductase activity. We compared the extent to which 11?-HSD1 in rat Leydig and liver cells might be coupled to H6PDH. In order to clarify the location of H6PDH within the testis, we used the Leydig cell toxicant ethane dimethanesulfonate (EDS) to selectively deplete Leydig cells. The depletion of Leydig cells eliminated Hsd11b1 (encoding 11?-HSD1) expression but did not affect the expression of H6pd (encoding H6PDH) and Slc37a4 (encoding G6P transporter). H6pd mRNA level and H6PDH activity were barely detectable in purified rat Leydig cells. In conclusion, the availability of H6PDH determines the different direction of 11?-HSD1 in liver and Leydig cells.
SUBMITTER: Li X
PROVIDER: S-EPMC4631333 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
Li Xingwang X Hu Guoxin G Li Xiaoheng X Wang Yi-Yan YY Hu Yuan-Yuan YY Zhou Hongyu H Latif Syed A SA Morris David J DJ Chu Yanhui Y Zheng Zhiqiang Z Ge Ren-Shan RS
PloS one 20151103 11
<h4>Background</h4>11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) interconverts active 11β-hydroxyl glucocorticoids and inactive 11keto forms. However, its directionality is determined by availability of NADP+/NADPH. In liver cells, 11β-HSD1 behaves as a primary reductase, while in Leydig cells it acts as a primary oxidase. However, the exact mechanism is not clear. The direction of 11β-HSD1 has been proposed to be regulated by hexose-6-phosphate dehydrogenase (H6PDH), which catalyzes glucose-6-p ...[more]